{
    "Trade/Device Name(s)": [
        "POGO Automatic Blood Glucose Monitoring System",
        "POGO\u00ae AutomaticTM Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Intuity Medical, Inc.",
    "510(k) Number": "K162203",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130265"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "April 6, 2017",
    "Summary Letter Received Date": "March 1, 2017",
    "Submission Date": "February 28, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "POGO Automatic Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric (LED)",
        "Glucose oxidase-based dry-reagent test strip"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Cartridge",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for POGO Automatic Blood Glucose Monitoring System for quantitative glucose measurement in capillary whole blood using integrated photometric technology.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips by a single person (adults/adolescents 13+), for self-testing at home to monitor effectiveness of diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}